The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
2022 · Leukemia · 3,654 citations
https://doi.org/10.1038/s41375-022-01613-1
T
Torsten Haferlach
BMW (Germany)(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
2.0K
Papers
61.0K
Citations
119
h-index
575
i10-index
Torsten Haferlach is an academic researcher from BMW (Germany). The author has contributed to research in topics: Acute Myeloid Leukemia Research & Myeloproliferative Neoplasms: Diagnosis and Treatment & Chronic Myeloid Leukemia Treatments. The author has an h-index of 119, co-authored 1729 publications.
ORCID: 0000-0003-0196-2837Papers by this author
worksMinimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
2018 · Blood · 1,009 citations
https://doi.org/10.1182/blood-2017-09-801498
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
2012 · Journal of Allergy and Clinical Immunology · 747 citations
https://doi.org/10.1016/j.jaci.2012.02.019
Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
2013 · Cancer Discovery · 717 citations
https://doi.org/10.1158/2159-8290.cd-13-0609
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
2021 · Blood · 681 citations
https://doi.org/10.1182/blood.2021013626
Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group
2010 · Journal of Clinical Oncology · 668 citations
https://doi.org/10.1200/jco.2009.23.4732
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat